USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$200.22M
Market Cap
-
P/E Ratio
-
EPS
$19.51
52 Week High
$0.51
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$3.1M |
Selling General And Administrative | $2.6M |
Research And Development | $493K |
Operating Expenses | $3.1M |
Investment Income Net | - |
Net Interest Income | -$243K |
Interest Income | $5.6K |
Interest Expense | $248K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$2.4M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$2.4M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$2.2M |
Net Income | -$2.4M |
Field | Value (USD) |
---|---|
Total Assets | $6.2M |
Total Current Assets | $4.7M |
Cash And Cash Equivalents At Carrying Value | $3.8M |
Cash And Short Term Investments | $3.8M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $1.6M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $881K |
Other Non Current Assets | - |
Total Liabilities | $2M |
Total Current Liabilities | $2M |
Current Accounts Payable | $279K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $197K |
Total Non Current Liabilities | $21K |
Capital Lease Obligations | $71K |
Long Term Debt | - |
Current Long Term Debt | $146K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $218K |
Other Current Liabilities | $1.5M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $4.2M |
Treasury Stock | - |
Retained Earnings | -$26M |
Common Stock | $3.3K |
Common Stock Shares Outstanding | $29M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$3.9M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $43K |
Capital Expenditures | $4 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $7.7M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$2.4M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$3.1M |
Selling General And Administrative | $2.6M |
Research And Development | $493K |
Operating Expenses | $3.1M |
Investment Income Net | - |
Net Interest Income | -$243K |
Interest Income | $5.6K |
Interest Expense | $248K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$2.4M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$2.4M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$2.2M |
Net Income | -$2.4M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily for the treatment of neuroinflammation. The company is headquartered in Jupiter, Florida.